| 1 | N acetyl cysteine | [1] Cysteine Cysteine | [2] L-Cysteine
L-Cysteine
,
Cysteine hydrochloride
💬
| - | - | [2] 6 6, 19 💬
|
| 2 | N Acetyl L Cysteine | [1] Cysteine Cysteine | [2] L-Cysteine
L-Cysteine
,
Cysteine hydrochloride
💬
| - | - | [1] 60 60 💬
|
| 3 | N Acetyl L Leucine | [1] Leucine Leucine | [1] Leucine
Leucine
💬
| - | - | [1] 19 19 💬
|
| 4 | N acetylcysteine | [1] Acetylcysteine Acetylcysteine | [1] Acetylcysteine
Acetylcysteine
💬
| - | - | [1] 13 13 💬
|
| 5 | N''-[(E)-[(2E)-3-[1-(2-nitrophenyl)-1H-pyrrol-2-yl]prop-2-en-1-ylidene]amino]guanidinium acetate | [1] Acetate Acetate | - | - | - | [1] 46 46 💬
|
| 6 | N(4,5Bis methanesulfonyl2methylbenzoyl) guanidine hydrochloride monohydrate | [1] Guanidine Guanidine | [1] Guanidine hydrochloride
Guanidine hydrochloride
💬
| - | - | [1] 113 113 💬
|
| 7 | N,N,N',N'-tetramethyl-10H-phenothiazine-3,7-diaminium bis(methanesulfonate) | [1] Phenothiazine Phenothiazine | [1] Phenothiazine
Phenothiazine
💬
| - | - | [1] 127 127 💬
|
| 8 | N,N,N?,N?-tetramethyl-10H-phenothiazine-3,7-diaminium bis(methanesulfonate) | [1] Phenothiazine Phenothiazine | [1] Phenothiazine
Phenothiazine
💬
| - | - | [1] 127 127 💬
|
| 9 | N,N,N’,N’-tetramethyl-10H-phenothiazine-3,7-diaminium bis(methanesulfonate) | [1] Phenothiazine Phenothiazine | [1] Phenothiazine
Phenothiazine
💬
| - | - | [1] 127 127 💬
|
| 10 | N-(4,5-Bis methanesulfonyl-2-methyl-benzoyl)guanidine hydrochloride monohydrate | [1] Guanidine Guanidine | [1] Guanidine hydrochloride
Guanidine hydrochloride
💬
| - | - | [1] 113 113 💬
|
| 11 | N-(5-hydroxy-2,4- bis(trimethylsilyl)phenyl)-4-oxo- 1,4-dihydroquinoline-3-carboxamide | - | - | - | - | [1] 299 299 💬
|
| 12 | N-(5-hydroxy-2,4-bis(trimethylsilyl)phenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide | - | - | - | - | [1] 299 299 💬
|
| 13 | N-(5-{4-[(3,3-dimethyl-1-azetidinyl)carbonyl]phenyl}[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide | - | - | - | - | [1] 49 49 💬
|
| 14 | N-(trans-3-(5-((R)-1-hydroxyethyl)-1,3,4-oxadiazol-2-yl)cyclobutyl)-3-phenylisoxazole-5-carboxamide | - | - | - | - | [1] 299 299 💬
|
| 15 | N-0923 | - | - | - | - | [1] 6 6 💬
|
| 16 | N-3 LC-PUFA | - | - | - | - | [1] 46 46 💬
|
| 17 | N-3 Polyunsaturated Fatty Acids | - | - | - | - | [1] 96 96 💬
|
| 18 | N-3 PUFAs | - | - | - | - | [1] 57 57 💬
|
| 19 | N-[1-((5-cyanopyridin-2-yl)methyl)-1H-pyrazol-3-yl]-2-[4-(1-(trifluoromethyl)cyclopropyl)phenyl]acetamide | [1] Acetamide Acetamide | - | - | - | [1] 154 154 💬
|
| 20 | N-acetyl Cysteine | [1] Cysteine Cysteine | [2] L-Cysteine
L-Cysteine
,
Cysteine hydrochloride
💬
| - | - | [6] 13 13, 34, 85, 88, 296, 310 💬
|
| 21 | N-Acetyl Cysteine (NAC) | [1] Cysteine Cysteine | [2] L-Cysteine
L-Cysteine
,
Cysteine hydrochloride
💬
| - | - | [1] 90 90 💬
|
| 22 | N-acetyl-cysteine | [1] Cysteine Cysteine | [2] L-Cysteine
L-Cysteine
,
Cysteine hydrochloride
💬
| - | - | [1] 84 84 💬
|
| 23 | N-Acetyl-L Leucine | [1] Leucine Leucine | [1] Leucine
Leucine
💬
| - | - | [1] 19 19 💬
|
| 24 | N-Acetyl-L-Leucine | [1] Leucine Leucine | [1] Leucine
Leucine
💬
| - | - | [3] 18 18, 19, 65 💬
|
| 25 | N-Acetyl-L-LeucineProduct Code: IB1001Pharmaceutical Form: Powder and solvent for oral solutionINN or Proposed INN: N-Acetyl-L-leucineOther descriptive name: 2(S)-(ACETYLAMINO)-4-METHYLPENTANOIC ACIDConcentration unit: g gram(s)Concentration type: equalConcentration number: 1-Product Name: N-Acetyl-L-LeucineProduct Code: IB1001Pharmaceutical Form: Granules for oral suspension in sachetINN or Proposed INN: N-Acetyl-L-leucineOther descriptive name: 2(S)-(ACETYLAMINO)-4-METHYLPENTANOIC ACIDConcentration unit: g gram(s)Concentration type: equalConcentration number: 1- | - | - | - | - | [1] 65 65 💬
|
| 26 | N-acetylcystein | - | - | - | - | [1] 299 299 💬
|
| 27 | N-Acetylcysteine | [1] Acetylcysteine Acetylcysteine | [1] Acetylcysteine
Acetylcysteine
💬
| - | - | [14] 6 6, 13, 19, 20, 21, 49, 58, 85, 90, 111, 164, 296, 299, 337 💬
|
| 28 | N-acetylcysteine (NAC) | [1] Acetylcysteine Acetylcysteine | [1] Acetylcysteine
Acetylcysteine
💬
| - | - | [3] 34 34, 51, 299 💬
|
| 29 | N-Acetylcysteine (NAC) Treatment | [1] Acetylcysteine Acetylcysteine | [1] Acetylcysteine
Acetylcysteine
💬
| - | - | [1] 6 6 💬
|
| 30 | N-Acetylcysteine Amide | [2] Acetylcysteine Acetylcysteine, Acetylcysteine amide | [1] Acetylcysteine
Acetylcysteine
💬
| - | - | [3] 19 19, 90, 303 💬
|
| 31 | N-acetylcysteine capsule | [1] Acetylcysteine Acetylcysteine | [1] Acetylcysteine
Acetylcysteine
💬
| - | - | [1] 6 6 💬
|
| 32 | N-acetylcysteine syrup | [1] Acetylcysteine Acetylcysteine | [1] Acetylcysteine
Acetylcysteine
💬
| - | - | [1] 53 53 💬
|
| 33 | N-Acetylcysteine, (NAC) | [1] Acetylcysteine Acetylcysteine | [1] Acetylcysteine
Acetylcysteine
💬
| - | - | [1] 85 85 💬
|
| 34 | N-acetylgalactosamine 4-sulfatase | - | - | - | - | [1] 19 19 💬
|
| 35 | N-Acetylglucosamine | [1] N-Acetylglucosamine N-Acetylglucosamine | - | - | - | [1] 96 96 💬
|
| 36 | N-Acetylglucosamine (GlcNAc) | [1] N-Acetylglucosamine N-Acetylglucosamine | - | - | - | [1] 96 96 💬
|
| 37 | N-acetylneuraminic acid | - | - | - | - | [1] 30 30 💬
|
| 38 | N-carbamylglutamate | - | - | - | - | [2] 245 245, 246 💬
|
| 39 | N-methyl D-(2,3,4,5,6-pentahydroxy-hexyl)-ammonium | - | - | - | - | [1] 28 28 💬
|
| 40 | N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine | - | - | - | - | [1] 13 13 💬
|
| 41 | N-{4-Chloro-2-[(1-oxido-4-pyridinyl)carbonyl]phenyl}-4-(1,1-dimethylethyl)benzenesulfonamide, sodium | - | - | - | - | [1] 96 96 💬
|
| 42 | N-{4-Chloro-2-[(1-oxido-4-pyridinyl)carbonyl]phenyl}-4-(1,1-dimethylethyl)benzenesulfonamidesodium | - | - | - | - | [1] 96 96 💬
|
| 43 | N. MENINGITIDIS GROUP C (STRAIN C11) OLIGOSACCHARIDE CONJUGATED TO | - | - | - | - | [1] 11 11 💬
|
| 44 | N. MENINGITIDIS GROUP C (STRAIN C11) OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 ADSORBED ON ALUMINUM HYDROXIDE | [2] Aluminum hydroxide Aluminum hydroxide, Corynebacterium diphtheriae | [3] Aluminum hydroxide
Aluminum hydroxide
,
Algeldrate
,
Almagate
💬
| - | - | [1] 11 11 💬
|
| 45 | N. MENINGITIDIS GROUP C POLYSACCHARIDE | - | - | - | - | [1] 14 14 💬
|
| 46 | N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM197 | - | - | - | - | [1] 13 13 💬
|
| 47 | N.a. | - | - | - | - | [11] 3 3, 6, 8, 13, 46, 63, 96, 97, 240, 256, 271 💬
|
| 48 | N/AProduct Code: RO7204239/F01-01Pharmaceutical Form: Solution for injectionINN or Proposed INN: N/ACAS Number: N/ACurrent Sponsor code: RO7204239Other descriptive name: GYM329Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 80-Pharmaceutical form of the placebo: Solution for injectionRoute of administration of the placebo: Subcutaneous use | - | - | - | - | [1] 3 3 💬
|
| 49 | N02BG10 | - | - | - | - | [1] 13 13 💬
|
| 50 | N03AX12 | - | - | - | - | [1] 13 13 💬
|
| 51 | N04BC07 | - | - | - | - | [1] 6 6 💬
|
| 52 | N04BD02 | - | - | - | - | [1] 6 6 💬
|
| 53 | N04BD03 | - | - | - | - | [1] 6 6 💬
|
| 54 | N06DX01 | - | - | - | - | [1] 13 13 💬
|
| 55 | N1,N3-BIS(2-MERCAPTOETHYL) ISOPHTHALAMIDE | - | - | - | - | [2] 5 5, 17 💬
|
| 56 | N6022 | - | - | - | - | [1] 299 299 💬
|
| 57 | N91115 | - | - | - | - | [1] 299 299 💬
|
| 58 | Na18F | - | - | - | - | [1] 13 13 💬
|
| 59 | Nab-sirolimus (also known as ABI-009, nab-rapamycin, albumin-bound rapamycin) | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬
| [1] MTOR MTOR 💬
| [52] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 86 86 💬
|
| 60 | NABILONE | [1] Nabilone Nabilone | [1] Nabilone
Nabilone
💬
| [2] CNR1 CNR1, CNR2 💬
| [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [4] 6 6, 13, 97, 127 💬
|
| 61 | Nabilone 0.25 mg | [1] Nabilone Nabilone | [1] Nabilone
Nabilone
💬
| [2] CNR1 CNR1, CNR2 💬
| [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 6 6 💬
|
| 62 | Nabiximols | [1] Nabiximols Nabiximols | [1] Nabiximols
Nabiximols
💬
| - | - | [1] 13 13 💬
|
| 63 | Nabiximols - Sativex | [1] Nabiximols Nabiximols | [1] Nabiximols
Nabiximols
💬
| - | - | [1] 13 13 💬
|
| 64 | NAC | - | - | - | - | [1] 8 8 💬
|
| 65 | NAC effervescent tablets | - | - | - | - | [1] 90 90 💬
|
| 66 | NaCl | - | - | - | - | [1] 227 227 💬
|
| 67 | NaCl 0,9% | - | - | - | - | [1] 53 53 💬
|
| 68 | NaCl 0.9% | - | - | - | - | [1] 39 39 💬
|
| 69 | Nacom | - | - | - | - | [1] 6 6 💬
|
| 70 | NACOM 100 | - | - | - | - | [1] 6 6 💬
|
| 71 | NACOM levodopa+cardidopa | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 72 | Nacystelyn | [1] Nacystelyn Nacystelyn | - | - | - | [1] 299 299 💬
|
| 73 | Nacystelyn® | [1] Nacystelyn Nacystelyn | - | - | - | [1] 299 299 💬
|
| 74 | NADH | [1] NADH NADH | - | - | - | [1] 302 302 💬
|
| 75 | Nadolol | [1] Nadolol Nadolol | [1] Nadolol
Nadolol
💬
| [2] ADRB1 ADRB1, ADRB2 💬
| [13] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬
|
| 76 | Naglazyme | - | - | - | - | [1] 19 19 💬
|
| 77 | Naglazyme (galsulfase) | [1] Galsulfase Galsulfase | [1] Galsulfase
Galsulfase
💬
| [1] ARSB ARSB 💬
| [2] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome biogenesis 💬 | [1] 19 19 💬
|
| 78 | Naglazyme® | - | - | - | - | [1] 19 19 💬
|
| 79 | NAL | - | - | - | - | [2] 6 6, 299 💬
|
| 80 | NAL ER | - | - | - | - | [1] 85 85 💬
|
| 81 | Nalbuphine | [1] Nalbuphine Nalbuphine | [2] Nalbuphine hydrochloride
Nalbuphine hydrochloride
,
Nalbuphine
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [7] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 85 85 💬
|
| 82 | Nalbuphine Extended-Realease (ER) Tablets | [1] Nalbuphine Nalbuphine | [2] Nalbuphine hydrochloride
Nalbuphine hydrochloride
,
Nalbuphine
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [7] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 85 85 💬
|
| 83 | Nalbuphine Extended-Release (ER) Tablets | [1] Nalbuphine Nalbuphine | [2] Nalbuphine hydrochloride
Nalbuphine hydrochloride
,
Nalbuphine
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [7] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 85 85 💬
|
| 84 | NALBUPHINE HYDROCHLORIDE | [1] Nalbuphine Nalbuphine | [2] Nalbuphine hydrochloride
Nalbuphine hydrochloride
,
Nalbuphine
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [7] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 85 85 💬
|
| 85 | Naldemedine | [1] Naldemedine Naldemedine | [2] Naldemedine
Naldemedine
,
Naldemedine tosylate
💬
| [1] OPRM1 OPRM1 💬
| [5] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [1] 6 6 💬
|
| 86 | Nalmefene | [1] Nalmefene Nalmefene | [3] Nalmefene hydrochloride
Nalmefene hydrochloride
,
Nalmefene
,
Nalmefene hydrochloride hydrate
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [7] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 6 6, 93 💬
|
| 87 | Naloxone | [1] Naloxone Naloxone | [3] Naloxone hydrochloride
Naloxone hydrochloride
,
Naloxone
,
Naloxone hydrochloride dihydrate
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [7] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 6 6, 226 💬
|
| 88 | NALOXONE HYDROCHLORIDE | [1] Naloxone Naloxone | [3] Naloxone hydrochloride
Naloxone hydrochloride
,
Naloxone
,
Naloxone hydrochloride dihydrate
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [7] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 226 226 💬
|
| 89 | NALOXONE HYDROCHLORIDE DIHYDRATE | [1] Naloxone Naloxone | [3] Naloxone hydrochloride
Naloxone hydrochloride
,
Naloxone
,
Naloxone hydrochloride dihydrate
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [7] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬
|
| 90 | Naltrexone | [1] Naltrexone Naltrexone | [2] Naltrexone hydrochloride
Naltrexone hydrochloride
,
Naltrexone
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [7] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [14] 6 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 49, 96, 97, 226 💬
|
| 91 | NALTREXONE CLORIDRATO | [1] Naltrexone Naltrexone | [2] Naltrexone hydrochloride
Naltrexone hydrochloride
,
Naltrexone
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [7] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 10 10 💬
|
| 92 | NALTREXONE HYDROCHLORIDE | [1] Naltrexone Naltrexone | [2] Naltrexone hydrochloride
Naltrexone hydrochloride
,
Naltrexone
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [7] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [9] 10 10, 40, 41, 42, 43, 44, 45, 96, 97 💬
|
| 93 | Naltrexone-HCl | [1] Naltrexone Naltrexone | [2] Naltrexone hydrochloride
Naltrexone hydrochloride
,
Naltrexone
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [7] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 96 96 💬
|
| 94 | NAMILUMAB | [1] Namilumab Namilumab | - | - | - | [2] 46 46, 84 💬
|
| 95 | Namilumab (MT203) | [1] Namilumab Namilumab | - | - | - | [1] 46 46 💬
|
| 96 | NamilumabProduct Code: KIN-1902Pharmaceutical Form: Solution for injectionINN or Proposed INN: NAMILUMABCAS Number: 1206681-39-1Current Sponsor code: KIN-1902 (previously IZN-101, MT203, AMG203)Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 150-Pharmaceutical form of the placebo: Solution for injectionRoute of administration of the placebo: Subcutaneous use | - | - | - | - | [1] 84 84 💬
|
| 97 | Namisol | - | - | - | - | [2] 13 13, 298 💬
|
| 98 | Namuscla | - | - | - | - | [2] 114 114, 115 💬
|
| 99 | NAND (Neoandrographolide) | - | - | - | - | [1] 97 97 💬
|
| 100 | Nandrolone | [1] Nandrolone Nandrolone | [1] Nandrolone
Nandrolone
💬
| [1] AR AR 💬
| [4] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | [2] 60 60, 85 💬
|
| 101 | Nandrolone Decanoate | [2] Nandrolone Nandrolone, Nandrolone decanoate | [2] Nandrolone decanoate
Nandrolone decanoate
,
Nandrolone
💬
| [1] AR AR 💬
| [4] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | [2] 60 60, 85 💬
|
| 102 | Nanobody directed towards the human A1 domain of von Willebrand factor | - | - | - | - | [1] 64 64 💬
|
| 103 | Nanobubble drink | - | - | - | - | [1] 46 46 💬
|
| 104 | Nanocort | - | - | - | - | [3] 13 13, 46, 97 💬
|
| 105 | Nanocrystalline silver (Acticoat) | [1] Silver Silver | - | - | - | [2] 35 35, 162 💬
|
| 106 | Nanocurcumin | - | - | - | - | [2] 13 13, 271 💬
|
| 107 | Nanogam | - | - | - | - | [2] 57 57, 63 💬
|
| 108 | Nanogam 100 mg/ml | - | - | - | - | [1] 65 65 💬
|
| 109 | Nanogam® 50 mg/ml | - | - | - | - | [1] 65 65 💬
|
| 110 | Nanoparticulated Rebamipide | [1] Rebamipide Rebamipide | [1] Rebamipide
Rebamipide
💬
| - | - | [1] 46 46 💬
|
| 111 | Nanosuspension) | - | - | - | - | [1] 113 113 💬
|
| 112 | Nap | - | - | - | - | [2] 96 96, 240 💬
|
| 113 | Napazimone | - | - | - | - | [1] 21 21 💬
|
| 114 | NaPBA | - | - | - | - | [1] 251 251 💬
|
| 115 | Naprosyn | - | - | - | - | [1] 271 271 💬
|
| 116 | Naprosyn 500 mg | - | - | - | - | [1] 46 46 💬
|
| 117 | Naprosysn | - | - | - | - | [1] 271 271 💬
|
| 118 | Naproxen | [1] Naproxen Naproxen | [2] Naproxen
Naproxen
,
Naproxen sodium
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [4] 13 13, 46, 107, 271 💬
|
| 119 | Naproxen (EC-Narosyn) Delayed Release Tables, 375 (Syntex (USA), Inc.) | [1] Naproxen Naproxen | [2] Naproxen
Naproxen
,
Naproxen sodium
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 💬
|
| 120 | Naproxen 10 mg/kg | [1] Naproxen Naproxen | [2] Naproxen
Naproxen
,
Naproxen sodium
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 💬
|
| 121 | Naproxen 500 mg tablets (PN 200 minus omeprazole) | [2] Naproxen Naproxen, Omeprazole | [5] Naproxen
Naproxen
,
Omeprazole
,
Naproxen sodium
,
Omeprazole sodium
,
Omeprazole magnesium
💬
| [4] ATP4A ATP4A, ATP4B, PTGS1, PTGS2 💬
| [26] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Collecting duct acid secretion, Efferocytosis, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [2] 46 46, 271 💬
|
| 122 | Naproxen Delayed Release Tables, 375 (Gevena Pharmaceuticals, Inc.) | [1] Naproxen Naproxen | [2] Naproxen
Naproxen
,
Naproxen sodium
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 💬
|
| 123 | Naproxen oral suspension | [1] Naproxen Naproxen | [2] Naproxen
Naproxen
,
Naproxen sodium
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 💬
|
| 124 | NAPROXEN SODIUM | [1] Naproxen Naproxen | [2] Naproxen
Naproxen
,
Naproxen sodium
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 107 107 💬
|
| 125 | Naproxen sodium 550mg tablet | [1] Naproxen Naproxen | [2] Naproxen
Naproxen
,
Naproxen sodium
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 💬
|
| 126 | Nardil | - | - | - | - | [1] 6 6 💬
|
| 127 | Narsoplimab | [1] Narsoplimab Narsoplimab | [1] Narsoplimab
Narsoplimab
💬
| [1] MASP2 MASP2 💬
| [3] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬 | [3] 66 66, 222, 223 💬
|
| 128 | Nasal Aztreonam | [1] Aztreonam Aztreonam | [2] Aztreonam
Aztreonam
,
Aztreonam lysine
💬
| - | - | [1] 299 299 💬
|
| 129 | Nasal Methylprednisolone (MT) | [1] Methylprednisolone Methylprednisolone | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 13 13 💬
|
| 130 | Nasal Nitric Oxide Measurement | [1] Nitric Oxide Nitric Oxide | [1] Nitric oxide
Nitric oxide
💬
| - | - | [1] 340 340 💬
|
| 131 | Nasal Nitric Oxide testing | [1] Nitric Oxide Nitric Oxide | [1] Nitric oxide
Nitric oxide
💬
| - | - | [1] 340 340 💬
|
| 132 | Nasal rinsing with saline 0.9% | - | - | - | - | [1] 299 299 💬
|
| 133 | Nasal rinsing with Xylitol | [1] Xylitol Xylitol | [1] Xylitol
Xylitol
💬
| - | - | [1] 299 299 💬
|
| 134 | Nasojejunal (NJ) tube | - | - | - | - | [1] 6 6 💬
|
| 135 | Nasonex | - | - | - | - | [1] 98 98 💬
|
| 136 | Nasopharyngeal (Nasal) Samples | - | - | - | - | [1] 340 340 💬
|
| 137 | Nasopharyngeal swabs | - | - | - | - | [1] 46 46 💬
|
| 138 | NATALIZUMAB | [1] Natalizumab Natalizumab | [1] Natalizumab
Natalizumab
💬
| [1] ITGA4 ITGA4 💬
| [17] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | [5] 13 13, 15, 25, 46, 96 💬
|
| 139 | Natalizumab (BG00002) | [1] Natalizumab Natalizumab | [1] Natalizumab
Natalizumab
💬
| [1] ITGA4 ITGA4 💬
| [17] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | [1] 13 13 💬
|
| 140 | Natalizumab (NTZ) | [1] Natalizumab Natalizumab | [1] Natalizumab
Natalizumab
💬
| [1] ITGA4 ITGA4 💬
| [17] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | [1] 13 13 💬
|
| 141 | Natalizumab (Tysabri) | [1] Natalizumab Natalizumab | [1] Natalizumab
Natalizumab
💬
| [1] ITGA4 ITGA4 💬
| [17] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | [1] 13 13 💬
|
| 142 | Natalizumab 300 MG in 15 ML Injection | [1] Natalizumab Natalizumab | [1] Natalizumab
Natalizumab
💬
| [1] ITGA4 ITGA4 💬
| [17] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | [1] 13 13 💬
|
| 143 | Natalizumab for IV Infusion | [1] Natalizumab Natalizumab | [1] Natalizumab
Natalizumab
💬
| [1] ITGA4 ITGA4 💬
| [17] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | [1] 13 13 💬
|
| 144 | Natalizumab for Subcutaneous Injection | [1] Natalizumab Natalizumab | [1] Natalizumab
Natalizumab
💬
| [1] ITGA4 ITGA4 💬
| [17] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | [1] 13 13 💬
|
| 145 | Natalizumab Injection [Tysabri] | [1] Natalizumab Natalizumab | [1] Natalizumab
Natalizumab
💬
| [1] ITGA4 ITGA4 💬
| [17] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | [1] 13 13 💬
|
| 146 | Natalizumab IV | [1] Natalizumab Natalizumab | [1] Natalizumab
Natalizumab
💬
| [1] ITGA4 ITGA4 💬
| [17] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | [1] 13 13 💬
|
| 147 | Natalizumab SC | [1] Natalizumab Natalizumab | [1] Natalizumab
Natalizumab
💬
| [1] ITGA4 ITGA4 💬
| [17] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | [1] 13 13 💬
|
| 148 | Natalizumab treatment | [1] Natalizumab Natalizumab | [1] Natalizumab
Natalizumab
💬
| [1] ITGA4 ITGA4 💬
| [17] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | [1] 13 13 💬
|
| 149 | Natpar | - | - | - | - | [1] 235 235 💬
|
| 150 | Natpara | - | - | - | - | [1] 235 235 💬
|
| 151 | NATPARA/NATPAR | - | - | - | - | [1] 235 235 💬
|
| 152 | Natriumchlorid 0,9 % | [1] Sodium chloride Sodium chloride | [1] Sodium chloride
Sodium chloride
💬
| - | - | [1] 288 288 💬
|
| 153 | Natriumklorid 9mg/ml | - | - | - | - | [1] 46 46 💬
|
| 154 | Natriuretic peptide | - | - | - | - | [1] 276 276 💬
|
| 155 | Natrunix | - | - | - | - | [1] 46 46 💬
|
| 156 | Natrunix 400 mg | - | - | - | - | [1] 46 46 💬
|
| 157 | Natural Matrix Protein (NMP) Fibers | - | - | - | - | [1] 70 70 💬
|
| 158 | NAV5001 | - | - | - | - | [1] 6 6 💬
|
| 159 | Navenibart | [1] Navenibart Navenibart | [1] Navenibart
Navenibart
💬
| [1] KLKB1 KLKB1 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 65 65 💬
|
| 160 | Navepegritide | [1] Navepegritide Navepegritide | [1] Navepegritide
Navepegritide
💬
| [1] NPR2 NPR2 💬
| [5] Hormone signaling Hormone signaling, Oxytocin signaling pathway, Purine metabolism, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 276 276 💬
|
| 161 | Navocaftor | [1] Navocaftor Navocaftor | [1] Navocaftor
Navocaftor
💬
| [1] CFTR CFTR 💬
| [9] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 162 | NB-4746 (Dose TBD) | - | - | - | - | [1] 2 2 💬
|
| 163 | NB-4746 High dose | - | - | - | - | [1] 2 2 💬
|
| 164 | NB-4746 Low dose | - | - | - | - | [1] 2 2 💬
|
| 165 | NBI-5788 | - | - | - | - | [1] 13 13 💬
|
| 166 | NBI-74788 | - | - | - | - | [1] 81 81 💬
|
| 167 | NBI-77860 | - | - | - | - | [1] 81 81 💬
|
| 168 | NBI-827104 | - | - | - | - | [1] 154 154 💬
|
| 169 | NBMI | - | - | - | - | [2] 5 5, 17 💬
|
| 170 | NBT-NM108 | - | - | - | - | [1] 193 193 💬
|
| 171 | NBT-NM108 (60 g/day) | - | - | - | - | [1] 13 13 💬
|
| 172 | NBTX-001 | - | - | - | - | [1] 6 6 💬
|
| 173 | NC 1 cell therapy | - | - | - | - | [1] 117 117 💬
|
| 174 | NC-503 (Anti-amyloidotic (AA) Agent) | - | - | - | - | [2] 46 46, 222 💬
|
| 175 | NCA 500mg | - | - | - | - | [1] 93 93 💬
|
| 176 | Nd | - | - | - | - | [6] 2 2, 6, 13, 46, 51, 97 💬
|
| 177 | ND-L02-s0201 (High Dose) | - | - | - | - | [1] 85 85 💬
|
| 178 | ND-L02-s0201 (Low Dose) | - | - | - | - | [1] 85 85 💬
|
| 179 | ND-L02-s0201 for injection | - | - | - | - | [1] 85 85 💬
|
| 180 | ND0611 | - | - | - | - | [1] 6 6 💬
|
| 181 | ND0612 | - | - | - | - | [1] 6 6 💬
|
| 182 | ND0612 (Levodopa/Carbidopa solution) | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 183 | ND0612 (Levodopa/Carbidopa solution) + morning oral IR-LD/CD | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 184 | ND1421 | - | - | - | - | [1] 6 6 💬
|
| 185 | ND1587 | - | - | - | - | [1] 6 6 💬
|
| 186 | ND1589 | - | - | - | - | [1] 6 6 💬
|
| 187 | ND1590 | - | - | - | - | [1] 6 6 💬
|
| 188 | ND1702 | - | - | - | - | [1] 6 6 💬
|
| 189 | NDI-5001 | [1] NDI-5001 NDI-5001 | - | - | - | [1] 225 225 💬
|
| 190 | NDV-3A | - | - | - | - | [1] 65 65 💬
|
| 191 | NDX-3315 | [1] NDX-3315 NDX-3315 | - | - | - | [1] 98 98 💬
|
| 192 | NDX-3324 | - | - | - | - | [1] 98 98 💬
|
| 193 | NE3107 | - | - | - | - | [1] 6 6 💬
|
| 194 | Near-infrared-induced autofluorescence and indocyanine green near-infrared angiography | [2] Indocyanine green Indocyanine green, Indocyanine green acid form | [1] Indocyanine green
Indocyanine green
💬
| - | - | [1] 235 235 💬
|
| 195 | NEB/01-07 | - | - | - | - | [1] 299 299 💬
|
| 196 | Nebcin | - | - | - | - | [1] 299 299 💬
|
| 197 | Nebcin (tobramycin) | [1] Tobramycin Tobramycin | [2] Tobramycin
Tobramycin
,
Tobramycin sulfate
💬
| - | - | [1] 299 299 💬
|
| 198 | Nebcinal | - | - | - | - | [1] 299 299 💬
|
| 199 | Nebcinal Tobi | - | - | - | - | [1] 299 299 💬
|
| 200 | NEBCINE | - | - | - | - | [1] 299 299 💬
|
| 201 | Nebicapone | [1] Nebicapone Nebicapone | - | - | - | [1] 6 6 💬
|
| 202 | NEBIDO | - | - | - | - | [1] 13 13 💬
|
| 203 | Nebido® Testosterone Undecanoate 1000 Mg/4 mL Solution for Injection | [2] Testosterone Testosterone, Testosterone undecanoate | [2] Testosterone
Testosterone
,
Testosterone undecanoate
💬
| [1] AR AR 💬
| [4] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | [1] 13 13 💬
|
| 204 | Nebivolol | [1] Nebivolol Nebivolol | [2] Nebivolol
Nebivolol
,
Nebivolol hydrochloride
💬
| [1] ADRB1 ADRB1 💬
| [13] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [4] 17 17, 85, 113, 167 💬
|
| 205 | Nebivolol 5 mg | [1] Nebivolol Nebivolol | [2] Nebivolol
Nebivolol
,
Nebivolol hydrochloride
💬
| [1] ADRB1 ADRB1 💬
| [13] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 17 17 💬
|
| 206 | Nebulization of Amikacin during NIV (RR: 15 cycles/minute) | [1] Amikacin Amikacin | [2] Amikacin sulfate
Amikacin sulfate
,
Amikacin
💬
| - | - | [1] 299 299 💬
|
| 207 | Nebulization of Amikacin during NIV (RR: 25 cycles/minute) | [1] Amikacin Amikacin | [2] Amikacin sulfate
Amikacin sulfate
,
Amikacin
💬
| - | - | [1] 299 299 💬
|
| 208 | Nebulization tobramycin | [1] Tobramycin Tobramycin | [2] Tobramycin
Tobramycin
,
Tobramycin sulfate
💬
| - | - | [1] 299 299 💬
|
| 209 | Nebulized combination ipratropium bromide with salbutamol | [1] Ipratropium Ipratropium | - | - | - | [1] 86 86 💬
|
| 210 | Nebulized Ensifentrine Suspension | [1] Ensifentrine Ensifentrine | [1] Ensifentrine
Ensifentrine
💬
| [6] PDE3A PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D 💬
| [11] Apelin signaling pathway Apelin signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 299 299 💬
|
| 211 | Nebulized ipratropium bromide | [1] Ipratropium Ipratropium | - | - | - | [1] 86 86 💬
|
| 212 | Nebulized nitroglycerin | [1] Nitroglycerin Nitroglycerin | [1] Nitroglycerin
Nitroglycerin
💬
| - | - | [1] 86 86 💬
|
| 213 | Nebulizer | - | - | - | - | [2] 6 6, 299 💬
|
| 214 | Necator americanus | - | - | - | - | [1] 13 13 💬
|
| 215 | Nedosiran | [1] Nedosiran Nedosiran | [1] Nedosiran sodium
Nedosiran sodium
💬
| [1] LDHA LDHA 💬
| [7] Central carbon metabolism in cancer Central carbon metabolism in cancer, Cysteine and methionine metabolism, Glucagon signaling pathway, Glycolysis / Gluconeogenesis, HIF-1 signaling pathway, Propanoate metabolism, Pyruvate metabolism 💬 | [1] 234 234 💬
|
| 216 | Needle biopsy of the vastus lateralis muscle | - | - | - | - | [1] 113 113 💬
|
| 217 | NEFECON | - | - | - | - | [2] 66 66, 223 💬
|
| 218 | Nefecon 16mg daily | - | - | - | - | [1] 66 66 💬
|
| 219 | Nefecon®,Ambrisentan | [1] Ambrisentan Ambrisentan | [1] Ambrisentan
Ambrisentan
💬
| [1] EDNRA EDNRA 💬
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 66 66 💬
|
| 220 | Neflamapimod | [1] Neflamapimod Neflamapimod | [1] Neflamapimod
Neflamapimod
💬
| [4] MAPK11 MAPK11, MAPK12, MAPK13, MAPK14 💬
| [64] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Alcoholic liver disease, Amyotrophic lateral sclerosis, C-type lectin receptor signaling pathway, Cadherin signaling, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Coronavirus disease, Diabetic cardiomyopathy, Dopaminergic synapse, Efferocytosis, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hepatitis B, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, IL-17 signaling pathway, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Oocyte meiosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Relaxin signaling pathway, Retrograde endocannabinoid signaling, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Yersinia infection 💬 | [1] 8 8 💬
|
| 221 | NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED WITH TETANUS TOXOID CARRIER PROTEIN | - | - | - | - | [1] 50 50 💬
|
| 222 | NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETA | - | - | - | - | [1] 50 50 💬
|
| 223 | NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN | - | - | - | - | [1] 50 50 💬
|
| 224 | Nelfinavir | [1] Nelfinavir Nelfinavir | [2] Nelfinavir mesylate
Nelfinavir mesylate
,
Nelfinavir
💬
| - | - | [3] 49 49, 265, 331 💬
|
| 225 | Nelfinavir mesylate | [1] Nelfinavir Nelfinavir | [2] Nelfinavir mesylate
Nelfinavir mesylate
,
Nelfinavir
💬
| - | - | [1] 265 265 💬
|
| 226 | Nelotanserin | [1] Nelotanserin Nelotanserin | [1] Nelotanserin
Nelotanserin
💬
| [1] HTR2A HTR2A 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬 | [1] 6 6 💬
|
| 227 | Nelutri™ | - | - | - | - | [1] 84 84 💬
|
| 228 | Nemolizumab | [1] Nemolizumab Nemolizumab | [1] Nemolizumab
Nemolizumab
💬
| [1] IL31RA IL31RA 💬
| [2] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬 | [1] 51 51 💬
|
| 229 | Neo-ASA | - | - | - | - | [1] 251 251 💬
|
| 230 | NEO-GAA | - | - | - | - | [1] 256 256 💬
|
| 231 | Neo-Recormon | - | - | - | - | [1] 18 18 💬
|
| 232 | NEOD001 | - | - | - | - | [1] 28 28 💬
|
| 233 | Neofordex | - | - | - | - | [1] 63 63 💬
|
| 234 | Neofordex 40 mg comprimés | - | - | - | - | [1] 63 63 💬
|
| 235 | Neofordex® | - | - | - | - | [1] 63 63 💬
|
| 236 | NeoFuse | - | - | - | - | [1] 70 70 💬
|
| 237 | NeoGAA | [1] Avalglucosidase alfa Avalglucosidase alfa | [1] Avalglucosidase alfa
Avalglucosidase alfa
💬
| [1] GAA GAA 💬
| [3] Galactose metabolism Galactose metabolism, Lysosome biogenesis, Starch and sucrose metabolism 💬 | [1] 256 256 💬
|
| 238 | NeoGAA or avalglucosidase alfa | [1] Avalglucosidase alfa Avalglucosidase alfa | [1] Avalglucosidase alfa
Avalglucosidase alfa
💬
| [1] GAA GAA 💬
| [3] Galactose metabolism Galactose metabolism, Lysosome biogenesis, Starch and sucrose metabolism 💬 | [1] 256 256 💬
|
| 239 | Neomycin | [1] Neomycin Neomycin | [3] Neomycin sulfate
Neomycin sulfate
,
Neomycin palmitate
,
Neomycin
💬
| - | - | [3] 96 96, 97, 296 💬
|
| 240 | Neophyr 1000ppm mol/mol | - | - | - | - | [1] 294 294 💬
|
| 241 | Neoral | - | - | - | - | [3] 60 60, 97, 222 💬
|
| 242 | NEORAL 100 mg, capsule molle | - | - | - | - | [1] 60 60 💬
|
| 243 | Neoral Oral Solution | - | - | - | - | [1] 269 269 💬
|
| 244 | Neoral Soft Gelatin Capsules | [1] Gelatin Gelatin | [1] Gelatin
Gelatin
💬
| - | - | [2] 97 97, 269 💬
|
| 245 | NeoRecormon | [1] Epoetin beta Epoetin beta | [1] Epoetin beta
Epoetin beta
💬
| [1] EPOR EPOR 💬
| [7] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [2] 13 13, 18 💬
|
| 246 | Neostigmine | [1] Neostigmine Neostigmine | [3] Neostigmine bromide
Neostigmine bromide
,
Neostigmine methylsulfate
,
Neostigmine
💬
| [1] ACHE ACHE 💬
| [3] Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | [1] 11 11 💬
|
| 247 | Neovasculgen | - | - | - | - | [1] 51 51 💬
|
| 248 | Neovasculgen® | - | - | - | - | [1] 226 226 💬
|
| 249 | Neramexane | [1] Neramexane Neramexane | - | - | - | [1] 13 13 💬
|
| 250 | Neramexane mesylate | [1] Neramexane Neramexane | - | - | - | [1] 13 13 💬
|
| 251 | Nerandomilast | [1] Nerandomilast Nerandomilast | [1] Nerandomilast
Nerandomilast
💬
| [1] PDE4B PDE4B 💬
| [4] Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [3] 2 2, 51, 85 💬
|
| 252 | Nerandomilast formulation 1 | [1] Nerandomilast Nerandomilast | [1] Nerandomilast
Nerandomilast
💬
| [1] PDE4B PDE4B 💬
| [4] Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [1] 51 51 💬
|
| 253 | Nerandomilast formulation 2 | [1] Nerandomilast Nerandomilast | [1] Nerandomilast
Nerandomilast
💬
| [1] PDE4B PDE4B 💬
| [4] Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [1] 51 51 💬
|
| 254 | Neratinib | [1] Neratinib Neratinib | [2] Neratinib
Neratinib
,
Neratinib maleate
💬
| [3] EGFR EGFR, ERBB2, ERBB4 💬
| [51] Adherens junction Adherens junction, Amyotrophic lateral sclerosis, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease, Cushing syndrome, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Tight junction, Virion - Hepatitis viruses 💬 | [1] 34 34 💬
|
| 255 | Neridronic Acid | [1] Neridronic Acid Neridronic Acid | - | - | - | [1] 6 6 💬
|
| 256 | Nerispirdine | [1] Nerispirdine Nerispirdine | - | - | - | [1] 13 13 💬
|
| 257 | Nerispirdine (HP184) | [1] Nerispirdine Nerispirdine | - | - | - | [1] 13 13 💬
|
| 258 | Nerispirdine hydrochloride | [1] Nerispirdine Nerispirdine | - | - | - | [1] 13 13 💬
|
| 259 | NERIXIA*IM EV 1F 25MG | - | - | - | - | [1] 6 6 💬
|
| 260 | NERIXIA*INFUS IV CONC 2F 100MG | - | - | - | - | [1] 274 274 💬
|
| 261 | Nerve block | - | - | - | - | [1] 46 46 💬
|
| 262 | Nerve Growt Factor - 2.5S | - | - | - | - | [1] 90 90 💬
|
| 263 | Nerve Growth Factor | [1] Nerve Growth Factor Nerve Growth Factor | - | - | - | [5] 2 2, 3, 18, 53, 90 💬
|
| 264 | Nesiritide | [1] Nesiritide Nesiritide | [1] Nesiritide
Nesiritide
💬
| [1] NPR1 NPR1 💬
| [10] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Hormone signaling, Oxytocin signaling pathway, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 57 57 💬
|
| 265 | Nessuno | - | - | - | - | [1] 96 96 💬
|
| 266 | Nestle IMPACT Immunonutrition | - | - | - | - | [1] 97 97 💬
|
| 267 | NET/EE | - | - | - | - | [1] 67 67 💬
|
| 268 | Neu-120 | - | - | - | - | [1] 6 6 💬
|
| 269 | NEU-411 | - | - | - | - | [1] 6 6 💬
|
| 270 | NEUPOGEN | - | - | - | - | [4] 13 13, 28, 51, 285 💬
|
| 271 | NEUPRO | - | - | - | - | [2] 6 6, 127 💬
|
| 272 | Neupro (Reference) | - | - | - | - | [1] 6 6 💬
|
| 273 | NEUPRO - 2 MG/24 H + 4 MG/24 H + 6 MG/24 H+ 8 MG/24 H CEROTTO OTTO TRANSDERMICO 7 CEROTTI + 7 CEROTTI + 7 CEROTTI + 7 CEROTTI TRANDERMICI IN BUSTINA | - | - | - | - | [1] 127 127 💬
|
| 274 | NEUPRO 2 mg/24 h parche transdérmico | - | - | - | - | [1] 6 6 💬
|
| 275 | Neupro 2 mg/24 h transdermal patch | - | - | - | - | [1] 6 6 💬
|
| 276 | Neupro 2mg/24 h transdermal patch | - | - | - | - | [1] 6 6 💬
|
| 277 | Neupro 2mg/24h transdermal patch | - | - | - | - | [1] 6 6 💬
|
| 278 | NEUPRO 4 mg/24 h parche transdérmico | - | - | - | - | [1] 6 6 💬
|
| 279 | Neupro 4 mg/24 h transdermal patch | - | - | - | - | [1] 6 6 💬
|
| 280 | Neupro 4mg/24 h transdermal patch | - | - | - | - | [1] 6 6 💬
|
| 281 | Neupro 4mg/24h transdermal patch | - | - | - | - | [1] 6 6 💬
|
| 282 | Neupro 4Mg/24Hr Transdermal Patch | - | - | - | - | [1] 6 6 💬
|
| 283 | NEUPRO 6 mg/24 h parche transdérmico | - | - | - | - | [1] 6 6 💬
|
| 284 | Neupro 6 mg/24 h transdermal patch | - | - | - | - | [1] 6 6 💬
|
| 285 | Neupro 6mg/24 h transdermal patch | - | - | - | - | [1] 6 6 💬
|
| 286 | Neupro 6mg/24h transdermal patch | - | - | - | - | [1] 6 6 💬
|
| 287 | NEUPRO 8 mg/24 h parche transdérmico | - | - | - | - | [1] 6 6 💬
|
| 288 | Neupro 8 mg/24 h transdermal patch | - | - | - | - | [1] 6 6 💬
|
| 289 | Neupro 8mg/24h transdermal patch | - | - | - | - | [1] 6 6 💬
|
| 290 | Neupro ® 8 mg | - | - | - | - | [1] 6 6 💬
|
| 291 | NEUPRO*28CER 2MG/24H | - | - | - | - | [1] 6 6 💬
|
| 292 | NEUPRO*28CER 4MG/24H | - | - | - | - | [1] 6 6 💬
|
| 293 | NEUPRO*28CER 6MG/24H | - | - | - | - | [1] 6 6 💬
|
| 294 | NEUPRO*28CER 8MG/24H | - | - | - | - | [1] 6 6 💬
|
| 295 | NEUPRO*7CER 4MG/24H | - | - | - | - | [1] 6 6 💬
|
| 296 | NEUPRO*7CER 6MG/24H | - | - | - | - | [1] 6 6 💬
|
| 297 | NEUPRO*7CER 8MG/24H | - | - | - | - | [1] 6 6 💬
|
| 298 | Neupro® | - | - | - | - | [1] 6 6 💬
|
| 299 | Neupro® 8 mg/24 h | - | - | - | - | [1] 6 6 💬
|
| 300 | Neuraceq | - | - | - | - | [1] 6 6 💬
|
| 301 | Neuro-muscular biopsy and lumbar puncture | - | - | - | - | [1] 2 2 💬
|
| 302 | NEUROASPIS PLP10® | - | - | - | - | [1] 13 13 💬
|
| 303 | NEUROBLOC | - | - | - | - | [1] 6 6 💬
|
| 304 | NeuroCell-PD | [1] NeuroCell-PD NeuroCell-PD | - | - | - | [1] 6 6 💬
|
| 305 | NeuroEPO | - | - | - | - | [1] 6 6 💬
|
| 306 | Neurohormonal mechanisms | - | - | - | - | [1] 127 127 💬
|
| 307 | Neurological evaluation | - | - | - | - | [1] 25 25 💬
|
| 308 | Neuromodulation - Sacral nerve stimulation | - | - | - | - | [1] 26 26 💬
|
| 309 | Neuromuscular electrical stimulation delivered using the electrical therapy device EMPI 300 PV | - | - | - | - | [1] 13 13 💬
|
| 310 | NEURONTIN | - | - | - | - | [1] 13 13 💬
|
| 311 | Neurontin 300 mg hard capsule | - | - | - | - | [2] 13 13, 18 💬
|
| 312 | Neurostimulation | - | - | - | - | [1] 6 6 💬
|
| 313 | NEUROSWING Orthosis (experimental) : carbon orthosis with an active ankle articulation | - | - | - | - | [1] 13 13 💬
|
| 314 | NeuroVax | [1] NeuroVax NeuroVax | - | - | - | [1] 13 13 💬
|
| 315 | NeuroVax 300ug/mL Dose for IM Injection | [1] NeuroVax NeuroVax | - | - | - | [1] 13 13 💬
|
| 316 | Neurpro | - | - | - | - | [1] 6 6 💬
|
| 317 | Nevanimibe | [1] Nevanimibe Nevanimibe | [2] Nevanimibe
Nevanimibe
,
Nevanimibe hydrochloride
💬
| - | - | [2] 75 75, 81 💬
|
| 318 | Nevanimibe hydrochloride | [1] Nevanimibe Nevanimibe | [2] Nevanimibe
Nevanimibe
,
Nevanimibe hydrochloride
💬
| - | - | [2] 75 75, 81 💬
|
| 319 | Nevirapine | [1] Nevirapine Nevirapine | [1] Nevirapine
Nevirapine
💬
| - | - | [1] 265 265 💬
|
| 320 | New formulation adalimumab | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 321 | New Formulation Etanercept | [1] Etanercept Etanercept | [1] Etanercept
Etanercept
💬
| [2] LTA LTA, TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 322 | New Formulation of rebif - human interferon beta-1a | [2] Human interferon beta Human interferon beta, Interferon beta-1a | [2] Interferon beta
Interferon beta
,
Interferon beta-1a
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬
|
| 323 | New TETA 4HCl Formulation | - | - | - | - | [1] 171 171 💬
|
| 324 | New thermo stable formulation of epoprostenol sodium | [1] Epoprostenol Epoprostenol | [2] Epoprostenol
Epoprostenol
,
Epoprostenol sodium
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
| 325 | NewGam | - | - | - | - | [3] 14 14, 63, 65 💬
|
| 326 | NewGam 10% | - | - | - | - | [1] 14 14 💬
|
| 327 | Newnorm | - | - | - | - | [1] 65 65 💬
|
| 328 | Nexavar | - | - | - | - | [1] 34 34 💬
|
| 329 | Nexavar (BAY 43-9006) (Sorafenib) | [1] Sorafenib Sorafenib | [2] Sorafenib tosylate
Sorafenib tosylate
,
Sorafenib
💬
| [8] BRAF BRAF, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1, RET 💬
| [90] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Cadherin signaling, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Influenza A, Insulin signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, VEGF signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 💬
|
| 330 | Nexiguran ziclumeran | - | - | - | - | [1] 28 28 💬
|
| 331 | Nexium | - | - | - | - | [1] 299 299 💬
|
| 332 | Nexium (esomeprazole magnesium) | [2] Esomeprazole Esomeprazole, Magnesium | [5] Esomeprazole magnesium
Esomeprazole magnesium
,
Esomeprazole sodium
,
Esomeprazole
,
Esomeprazole strontium
,
Esomeprazole magnesium dihydrate
💬
| [2] ATP4A ATP4A, ATP4B 💬
| [3] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | [1] 298 298 💬
|
| 333 | Nexium 10 mg | - | - | - | - | [1] 234 234 💬
|
| 334 | Nexium 20 | - | - | - | - | [1] 299 299 💬
|
| 335 | Next Generation Dome Helmet Focused Ultrasound | - | - | - | - | [1] 2 2 💬
|
| 336 | Nexviadyme | - | - | - | - | [1] 256 256 💬
|
| 337 | NFC-1 | - | - | - | - | [1] 203 203 💬
|
| 338 | NFS-02 | [1] NFS-02 NFS-02 | - | - | - | [1] 302 302 💬
|
| 339 | NFS-02 Injection | [1] NFS-02 NFS-02 | - | - | - | [1] 302 302 💬
|
| 340 | NFX-179 Gel | - | - | - | - | [1] 34 34 💬
|
| 341 | Ng-monomethyl-L-arginine (drug) | [2] Arginine Arginine, L-arginine | [3] Arginine hydrochloride
Arginine hydrochloride
,
Arginine
,
Arginine hydrochloride
💬
| - | - | [2] 67 67, 223 💬
|
| 342 | NG01 - Autologous bone marrow derived human stromal cells | - | - | - | - | [1] 13 13 💬
|
| 343 | NGGT002 | - | - | - | - | [1] 240 240 💬
|
| 344 | NGGT006 | - | - | - | - | [1] 79 79 💬
|
| 345 | NGM/EE | - | - | - | - | [1] 67 67 💬
|
| 346 | NGM282 | - | - | - | - | [2] 93 93, 94 💬
|
| 347 | NGN-101 | [1] NGN-101 NGN-101 | - | - | - | [1] 19 19 💬
|
| 348 | NGN-401 | [1] NGN-401 NGN-401 | - | - | - | [1] 156 156 💬
|
| 349 | NGS | - | - | - | - | [2] 61 61, 63 💬
|
| 350 | NGX267 | [1] NGX267 NGX267 | - | - | - | [1] 53 53 💬
|
| 351 | NHS7108 | - | - | - | - | [1] 299 299 💬
|
| 352 | NI-0101 | - | - | - | - | [1] 46 46 💬
|
| 353 | NI-03 | - | - | - | - | [1] 298 298 💬
|
| 354 | NI-0401 (anti-CD3 mAB) | - | - | - | - | [1] 96 96 💬
|
| 355 | NI-0501 | - | - | - | - | [3] 49 49, 54, 107 💬
|
| 356 | NI-071 | - | - | - | - | [1] 46 46 💬
|
| 357 | NI-0801 | - | - | - | - | [1] 93 93 💬
|
| 358 | Niacin | [1] Niacin Niacin | [1] Niacin
Niacin
💬
| - | - | [4] 6 6, 46, 79, 265 💬
|
| 359 | Niacin sustained release capsules | [1] Niacin Niacin | [1] Niacin
Niacin
💬
| - | - | [1] 46 46 💬
|
| 360 | Niacinamide | - | - | - | - | [3] 6 6, 13, 67 💬
|
| 361 | Nicardipine | [1] Nicardipine Nicardipine | [2] Nicardipine hydrochloride
Nicardipine hydrochloride
,
Nicardipine
💬
| [4] CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| [37] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 70 70, 86 💬
|
| 362 | Niclosamide | [1] Niclosamide Niclosamide | [1] Niclosamide
Niclosamide
💬
| - | - | [2] 46 46, 97 💬
|
| 363 | Nicolon | - | - | - | - | [1] 97 97 💬
|
| 364 | Nicorandil | [1] Nicorandil Nicorandil | [1] Nicorandil
Nicorandil
💬
| [6] ABCC8 ABCC8, ABCC9, GUCY1A1, GUCY1A2, GUCY1B1, KCNJ11 💬
| [14] ABC transporters ABC transporters, Circadian entrainment, Gap junction, GnRH secretion, Insulin secretion, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Type II diabetes mellitus, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 46 46 💬
|
| 365 | Nicorandil 5 MG Oral Tablet | [1] Nicorandil Nicorandil | [1] Nicorandil
Nicorandil
💬
| [6] ABCC8 ABCC8, ABCC9, GUCY1A1, GUCY1A2, GUCY1B1, KCNJ11 💬
| [14] ABC transporters ABC transporters, Circadian entrainment, Gap junction, GnRH secretion, Insulin secretion, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Type II diabetes mellitus, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 46 46 💬
|
| 366 | Nicorette 10mg/ 16 h | - | - | - | - | [1] 6 6 💬
|
| 367 | Nicorette 15 mg/ 16 h | - | - | - | - | [1] 6 6 💬
|
| 368 | Nicorette 5 mg/ 16 h | - | - | - | - | [1] 6 6 💬
|
| 369 | Nicotinamid riboside | - | - | - | - | [1] 13 13 💬
|
| 370 | Nicotinamide | [1] Nicotinamide Nicotinamide | [1] Niacinamide
Niacinamide
💬
| - | - | [19] 2 2, 5, 6, 7, 8, 17, 18, 21, 46, 49, 60, 63, 65, 85, 97, 107, 162, 191, 302 💬
|
| 371 | Nicotinamide adenine dinucleotid/nicotinamide mononucleotide | [3] Adenine Adenine, Nicotinamide, Nicotinamide Mononucleotide | [2] Adenine
Adenine
,
Niacinamide
💬
| - | - | [1] 63 63 💬
|
| 372 | Nicotinamide Mononucleotide | [2] Nicotinamide Nicotinamide, Nicotinamide Mononucleotide | [1] Niacinamide
Niacinamide
💬
| - | - | [2] 63 63, 97 💬
|
| 373 | Nicotinamide riboside | [2] Nicotinamide Nicotinamide, Nicotinamide riboside | [1] Niacinamide
Niacinamide
💬
| - | - | [14] 2 2, 5, 6, 7, 8, 17, 18, 21, 49, 60, 65, 85, 97, 191 💬
|
| 374 | Nicotinamide Riboside (NR) | [2] Nicotinamide Nicotinamide, Nicotinamide riboside | [1] Niacinamide
Niacinamide
💬
| - | - | [1] 8 8 💬
|
| 375 | Nicotinamide Riboside Chloride | [2] Nicotinamide Nicotinamide, Nicotinamide riboside | [1] Niacinamide
Niacinamide
💬
| - | - | [1] 97 97 💬
|
| 376 | Nicotinamide Tablet | [1] Nicotinamide Nicotinamide | [1] Niacinamide
Niacinamide
💬
| - | - | [1] 46 46 💬
|
| 377 | Nicotinamide treatment | [1] Nicotinamide Nicotinamide | [1] Niacinamide
Niacinamide
💬
| - | - | [2] 21 21, 302 💬
|
| 378 | NICOTINE | [1] Nicotine Nicotine | [3] Nicotine
Nicotine
,
Nicotine bitartrate
,
Nicotine polacrilex
💬
| [16] CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬
| [9] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬 | [3] 6 6, 13, 84 💬
|
| 379 | Nicotine gum | [1] Nicotine Nicotine | [3] Nicotine
Nicotine
,
Nicotine bitartrate
,
Nicotine polacrilex
💬
| [16] CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬
| [9] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬 | [1] 6 6 💬
|
| 380 | Nicotine Nasal Spray 10 MG/ML (0.5 MG/SPRAY) | [1] Nicotine Nicotine | [3] Nicotine
Nicotine
,
Nicotine bitartrate
,
Nicotine polacrilex
💬
| [16] CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬
| [9] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬 | [1] 6 6 💬
|
| 381 | Nicotine patch | [1] Nicotine Nicotine | [3] Nicotine
Nicotine
,
Nicotine bitartrate
,
Nicotine polacrilex
💬
| [16] CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬
| [9] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬 | [2] 6 6, 84 💬
|
| 382 | Nicotine transdermal patch | [1] Nicotine Nicotine | [3] Nicotine
Nicotine
,
Nicotine bitartrate
,
Nicotine polacrilex
💬
| [16] CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬
| [9] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬 | [1] 6 6 💬
|
| 383 | Nicotinell | - | - | - | - | [1] 6 6 💬
|
| 384 | Nicotinell 17,5 mg/24-Stunden-Pflaster | - | - | - | - | [1] 6 6 💬
|
| 385 | Nicotinell 35 mg/24-Stunden-Pflaster | - | - | - | - | [1] 6 6 💬
|
| 386 | Nicotinic acid | - | - | - | - | [1] 79 79 💬
|
| 387 | Nicotinic acid/laropiprant | [2] Laropiprant Laropiprant, Niacin | [2] Niacin
Niacin
,
Laropiprant
💬
| [1] PTGDR PTGDR 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 79 79 💬
|
| 388 | NIDO-361 | - | - | - | - | [1] 1 1 💬
|
| 389 | Nifedipine | [1] Nifedipine Nifedipine | [1] Nifedipine
Nifedipine
💬
| [4] CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| [37] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 50 50, 81 💬
|
| 390 | Nifuroxazide | [1] Nifuroxazide Nifuroxazide | [1] Nifuroxazide
Nifuroxazide
💬
| - | - | [1] 97 97 💬
|
| 391 | Nilemdo | - | - | - | - | [1] 79 79 💬
|
| 392 | Nilemdo Product Name: bempedoic acidPharmaceutical Form: TabletINN or Proposed INN: Bempedoic acidCAS Number: 738606-46-7 Current Sponsor code: ETC-1002 | - | - | - | - | [1] 79 79 💬
|
| 393 | Nilotinib | [1] Nilotinib Nilotinib | [1] Nilotinib
Nilotinib
💬
| [4] ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬
| [35] Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [5] 6 6, 8, 34, 51, 86 💬
|
| 394 | Nilotinib (Tasigna) | [1] Nilotinib Nilotinib | [1] Nilotinib
Nilotinib
💬
| [4] ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬
| [35] Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [1] 51 51 💬
|
| 395 | Nilotinib 150 MG | [1] Nilotinib Nilotinib | [1] Nilotinib
Nilotinib
💬
| [4] ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬
| [35] Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [1] 8 8 💬
|
| 396 | Nilotinib 150mg oral capsule [Tasigna] | [1] Nilotinib Nilotinib | [1] Nilotinib
Nilotinib
💬
| [4] ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬
| [35] Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [1] 6 6 💬
|
| 397 | Nilotinib 300mg oral capsule [Tasigna] | [1] Nilotinib Nilotinib | [1] Nilotinib
Nilotinib
💬
| [4] ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬
| [35] Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [1] 6 6 💬
|
| 398 | Nilotinib 50 mg | [1] Nilotinib Nilotinib | [1] Nilotinib
Nilotinib
💬
| [4] ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬
| [35] Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [1] 86 86 💬
|
| 399 | NILOTINIB HYDROCHLORIDE MONOHYDRATE | [1] Nilotinib Nilotinib | [1] Nilotinib
Nilotinib
💬
| [4] ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬
| [35] Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [1] 34 34 💬
|
| 400 | Nilvadipine | [1] Nilvadipine Nilvadipine | [1] Nilvadipine
Nilvadipine
💬
| [4] CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| [37] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 90 90 💬
|
| 401 | Nimenrix | - | - | - | - | [4] 50 50, 61, 63, 223 💬
|
| 402 | Nimesulide | [1] Nimesulide Nimesulide | [1] Nimesulide
Nimesulide
💬
| [1] PTGS2 PTGS2 💬
| [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 💬
|
| 403 | Ninerafaxstat | [1] Ninerafaxstat Ninerafaxstat | [1] Ninerafaxstat
Ninerafaxstat
💬
| - | - | [1] 58 58 💬
|
| 404 | Ninerafaxstat 200mg MR | [1] Ninerafaxstat Ninerafaxstat | [1] Ninerafaxstat
Ninerafaxstat
💬
| - | - | [1] 58 58 💬
|
| 405 | Ninlaro | - | - | - | - | [2] 61 61, 63 💬
|
| 406 | NINTEDANIB | [1] Nintedanib Nintedanib | [2] Nintedanib esylate
Nintedanib esylate
,
Nintedanib
💬
| [8] FGFR1 FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬
| [36] Adherens junction Adherens junction, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | [7] 51 51, 84, 85, 89, 227, 228, 331 💬
|
| 407 | Nintedanib 150 mg and 100 mg soft capsules | [1] Nintedanib Nintedanib | [2] Nintedanib esylate
Nintedanib esylate
,
Nintedanib
💬
| [8] FGFR1 FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬
| [36] Adherens junction Adherens junction, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | [1] 227 227 💬
|
| 408 | Nintedanib,Dextromethorphan | [2] Dextromethorphan Dextromethorphan, Nintedanib | [5] Dextromethorphan hydrobromide
Dextromethorphan hydrobromide
,
Dextromethorphan
,
Dextromethorphan polistirex
,
Nintedanib esylate
,
Nintedanib
💬
| [14] FGFR1 FGFR1, FGFR2, FGFR3, FLT1, FLT4, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, KDR, PDGFRA, PDGFRB, SIGMAR1 💬
| [54] Adherens junction Adherens junction, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, Glutamatergic synapse, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Huntington disease, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, Long-term potentiation, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prion disease, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Spinocerebellar ataxia, Systemic lupus erythematosus, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway, cAMP signaling pathway 💬 | [1] 85 85 💬
|
| 409 | Nintendo Wii Fit Balance Board | - | - | - | - | [1] 13 13 💬
|
| 410 | Nintédanib | - | - | - | - | [1] 227 227 💬
|
| 411 | NIOX MINO® Airway Inflammation Monitor | - | - | - | - | [1] 98 98 💬
|
| 412 | NIP292 | - | - | - | - | [1] 85 85 💬
|
| 413 | NIP292 tablet | - | - | - | - | [1] 85 85 💬
|
| 414 | NIP292 tablets | - | - | - | - | [1] 85 85 💬
|
| 415 | Nipocalimab | [1] Nipocalimab Nipocalimab | [1] Nipocalimab
Nipocalimab
💬
| - | - | [6] 11 11, 14, 46, 49, 53, 61 💬
|
| 416 | Nipocalimab Product Code: JNJ-80202135Pharmaceutical Form: Solution for infusionINN or Proposed INN: NipocalimabCAS Number: 2211985-36-1Current Sponsor code: JNJ-80202135Other descriptive name: M281Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 30-Pharmaceutical form of the placebo: Solution for infusionRoute of administration of the placebo: Intravenous use | [1] Nipocalimab Nipocalimab | [1] Nipocalimab
Nipocalimab
💬
| - | - | [1] 11 11 💬
|
| 417 | Nipocalimab SC-LIV | [1] Nipocalimab Nipocalimab | [1] Nipocalimab
Nipocalimab
💬
| - | - | [1] 11 11 💬
|
| 418 | NIRS | - | - | - | - | [1] 97 97 💬
|
| 419 | NIRS after bosentan administration | [1] Bosentan Bosentan | [2] Bosentan
Bosentan
,
Bosentan
💬
| [2] EDNRA EDNRA, EDNRB 💬
| [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 13 13 💬
|
| 420 | NIRS baseline | - | - | - | - | [1] 13 13 💬
|
| 421 | Nitazoxanide | [1] Nitazoxanide Nitazoxanide | [1] Nitazoxanide
Nitazoxanide
💬
| - | - | [3] 46 46, 96, 97 💬
|
| 422 | Nitazoxanide 500Mg Oral Tablet | [1] Nitazoxanide Nitazoxanide | [1] Nitazoxanide
Nitazoxanide
💬
| - | - | [2] 46 46, 97 💬
|
| 423 | NITISINONE | [1] Nitisinone Nitisinone | [1] Nitisinone
Nitisinone
💬
| [1] HPD HPD 💬
| [3] Phenylalanine metabolism Phenylalanine metabolism, Tyrosine metabolism, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | [3] 6 6, 164, 241 💬
|
| 424 | Nitisinone 10 mg Tablet High Compritol | [1] Nitisinone Nitisinone | [1] Nitisinone
Nitisinone
💬
| [1] HPD HPD 💬
| [3] Phenylalanine metabolism Phenylalanine metabolism, Tyrosine metabolism, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | [1] 241 241 💬
|
| 425 | Nitisinone Baked Tablet | [1] Nitisinone Nitisinone | [1] Nitisinone
Nitisinone
💬
| [1] HPD HPD 💬
| [3] Phenylalanine metabolism Phenylalanine metabolism, Tyrosine metabolism, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | [1] 241 241 💬
|
| 426 | Nitrate | [1] Nitrate Nitrate | [1] Nitric acid
Nitric acid
💬
| - | - | [6] 57 57, 58, 67, 85, 113, 299 💬
|
| 427 | Nitrate-depleted beetroot juice | [1] Nitrate Nitrate | [1] Nitric acid
Nitric acid
💬
| - | - | [1] 67 67 💬
|
| 428 | Nitrate-rich beetroot juice (70ml with approx. 400 mg nitrate) twice a day for 3 days | [1] Nitrate Nitrate | [1] Nitric acid
Nitric acid
💬
| - | - | [1] 85 85 💬
|
| 429 | Nitrazepam | [1] Nitrazepam Nitrazepam | [1] Nitrazepam
Nitrazepam
💬
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| [9] Cadherin signaling Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 145 145 💬
|
| 430 | Nitric Oxide | [1] Nitric Oxide Nitric Oxide | [1] Nitric oxide
Nitric oxide
💬
| - | - | [12] 46 46, 51, 85, 86, 88, 97, 98, 210, 251, 294, 299, 340 💬
|
| 431 | Nitric Oxide 160 ppm | [1] Nitric Oxide Nitric Oxide | [1] Nitric oxide
Nitric oxide
💬
| - | - | [1] 299 299 💬
|
| 432 | Nitric Oxide for inhalation | [1] Nitric Oxide Nitric Oxide | [1] Nitric oxide
Nitric oxide
💬
| - | - | [2] 86 86, 299 💬
|
| 433 | Nitric Oxide generated by the GeNO nitrosyl delivery system | [1] Nitric Oxide Nitric Oxide | [1] Nitric oxide
Nitric oxide
💬
| - | - | [1] 86 86 💬
|
| 434 | Nitric Oxide plus Oxygen | [2] Nitric Oxide Nitric Oxide, Oxygen | [2] Oxygen
Oxygen
,
Nitric oxide
💬
| - | - | [1] 86 86 💬
|
| 435 | Nitric oxide supplement | [1] Nitric Oxide Nitric Oxide | [1] Nitric oxide
Nitric oxide
💬
| - | - | [1] 251 251 💬
|
| 436 | Nitrite | [1] Nitrite Nitrite | - | - | - | [3] 58 58, 86, 299 💬
|
| 437 | Nitrofurantoin | [1] Nitrofurantoin Nitrofurantoin | [1] Nitrofurantoin
Nitrofurantoin
💬
| - | - | [1] 13 13 💬
|
| 438 | Nitrogen | [1] Nitrogen Nitrogen | [1] Nitrogen
Nitrogen
💬
| - | - | [6] 5 5, 6, 17, 171, 211, 299 💬
|
| 439 | Nitroglycerin | [1] Nitroglycerin Nitroglycerin | [1] Nitroglycerin
Nitroglycerin
💬
| - | - | [2] 51 51, 86 💬
|
| 440 | Nitroglycerin Ointment 2% | [1] Nitroglycerin Nitroglycerin | [1] Nitroglycerin
Nitroglycerin
💬
| - | - | [1] 51 51 💬
|
| 441 | Nitroglycerine gel | - | - | - | - | [1] 51 51 💬
|
| 442 | Nitroprusside | [1] Nitroprusside Nitroprusside | [1] Sodium nitroprusside
Sodium nitroprusside
💬
| - | - | [1] 51 51 💬
|
| 443 | Nitrous Oxide | [1] Nitrous oxide Nitrous oxide | [1] Nitrous oxide
Nitrous oxide
💬
| - | - | [1] 34 34 💬
|
| 444 | NiuBangZi pill | - | - | - | - | [1] 46 46 💬
|
| 445 | Nivolumab | [1] Nivolumab Nivolumab | [1] Nivolumab
Nivolumab
💬
| [1] PDCD1 PDCD1 💬
| [3] Cell adhesion molecule (CAM) interaction Cell adhesion molecule (CAM) interaction, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬 | [12] 13 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬
|
| 446 | NIZORAL | - | - | - | - | [1] 75 75 💬
|
| 447 | Nizubaglustat | [1] Nizubaglustat Nizubaglustat | [1] Nizubaglustat
Nizubaglustat
💬
| [2] GBA2 GBA2, UGCG 💬
| [3] Cornified envelope formation Cornified envelope formation, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 448 | NJ-Tube: Silicon ED Tube | [1] Silicon Silicon | - | - | - | [1] 6 6 💬
|
| 449 | NK 010 or NK042 | - | - | - | - | [1] 49 49 💬
|
| 450 | NK 104 | - | - | - | - | [1] 79 79 💬
|
| 451 | NK cells | - | - | - | - | [1] 26 26 💬
|
| 452 | NK042 | - | - | - | - | [1] 13 13 💬
|
| 453 | NK510 : allogeneic genetic modified NK | - | - | - | - | [1] 49 49 💬
|
| 454 | NKX019 | - | - | - | - | [4] 46 46, 49, 51, 222 💬
|
| 455 | NL-ATN1-001 | - | - | - | - | [1] 18 18 💬
|
| 456 | NL-ATN1-002 | - | - | - | - | [1] 18 18 💬
|
| 457 | NL-CHCHD-001 | - | - | - | - | [1] 2 2 💬
|
| 458 | NL-FLVC-001 | - | - | - | - | [1] 90 90 💬
|
| 459 | NL-GARS1-001 | - | - | - | - | [1] 10 10 💬
|
| 460 | NL-TARD-001 | - | - | - | - | [1] 2 2 💬
|
| 461 | NL003 | - | - | - | - | [1] 47 47 💬
|
| 462 | Nle4-D-Phe7-alpha-MSH | - | - | - | - | [1] 254 254 💬
|
| 463 | NLX-112 | - | - | - | - | [1] 6 6 💬
|
| 464 | NLY01 | - | - | - | - | [2] 6 6, 13 💬
|
| 465 | NM8074 | - | - | - | - | [5] 50 50, 62, 66, 109, 223 💬
|
| 466 | NMD670 | - | - | - | - | [3] 3 3, 10, 11 💬
|
| 467 | NNC 0109-0000-0012 | - | - | - | - | [1] 46 46 💬
|
| 468 | NNC 0141-0000-0100 | - | - | - | - | [1] 46 46 💬
|
| 469 | NNC 0142-0000-0002 | - | - | - | - | [2] 46 46, 96 💬
|
| 470 | NNC 0151-0000-0000 | - | - | - | - | [2] 46 46, 49 💬
|
| 471 | NNC 142-0002 | - | - | - | - | [1] 46 46 💬
|
| 472 | NNC0109-0012 | - | - | - | - | [1] 46 46 💬
|
| 473 | NNC0114-0000-0005 | - | - | - | - | [1] 46 46 💬
|
| 474 | NNC0114-0006 | [1] NNC0114-0006 NNC0114-0006 | - | - | - | [3] 46 46, 49, 96 💬
|
| 475 | NNC0142-0000-0002 | - | - | - | - | [1] 96 96 💬
|
| 476 | NNC0142-0002 | - | - | - | - | [1] 46 46 💬
|
| 477 | NNC0151-0000-0000 | - | - | - | - | [1] 46 46 💬
|
| 478 | NNC0215-0384 | - | - | - | - | [2] 46 46, 162 💬
|
| 479 | NNC109-0012 | - | - | - | - | [1] 46 46 💬
|
| 480 | NNC142-0002 | - | - | - | - | [1] 96 96 💬
|
| 481 | NNC151-0000 | - | - | - | - | [1] 46 46 💬
|
| 482 | NNC6019-0001 | - | - | - | - | [1] 28 28 💬
|
| 483 | NNC6019-0001 A 250 mg | - | - | - | - | [1] 28 28 💬
|
| 484 | NNZ-2566 | - | - | - | - | [2] 156 156, 206 💬
|
| 485 | NNZ-2591 | [1] NNZ-2591 NNZ-2591 | - | - | - | [2] 193 193, 201 💬
|
| 486 | No | - | - | - | - | [3] 46 46, 62, 299 💬
|
| 487 | NO4BD03 | - | - | - | - | [1] 6 6 💬
|
| 488 | Nocturnal oxygen , nocturnal bi-level positive pressure ventilation | [1] Oxygen Oxygen | [1] Oxygen
Oxygen
💬
| - | - | [1] 299 299 💬
|
| 489 | NOE-101 | - | - | - | - | [1] 158 158 💬
|
| 490 | Nolpitantium Besylate | - | - | - | - | [1] 97 97 💬
|
| 491 | NOMACOPAN | [1] Nomacopan Nomacopan | [1] Nomacopan
Nomacopan
💬
| [1] C5 C5 💬
| [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 162 162 💬
|
| 492 | Nomacopan (rVA576) | [1] Nomacopan Nomacopan | [1] Nomacopan
Nomacopan
💬
| [1] C5 C5 💬
| [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 162 162 💬
|
| 493 | Nomegestrol | [1] Nomegestrol Nomegestrol | [1] Nomegestrol
Nomegestrol
💬
| [1] PGR PGR 💬
| [5] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | [1] 13 13 💬
|
| 494 | Nomegestrol acetate | [3] Acetate Acetate, Nomegestrol, Nomegestrol acetate | [2] Nomegestrol
Nomegestrol
,
Nomegestrol acetate
💬
| [1] PGR PGR 💬
| [5] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | [1] 13 13 💬
|
| 495 | Nomlabofusp | [1] Nomlabofusp Nomlabofusp | - | - | - | [1] 18 18 💬
|
| 496 | NON APPLICABILE | - | - | - | - | [3] 49 49, 51, 256 💬
|
| 497 | Non applicable | - | - | - | - | [2] 10 10, 19 💬
|
| 498 | Non as of yet | - | - | - | - | [1] 97 97 💬
|
| 499 | Non ATG Conditioning regimen | - | - | - | - | [1] 60 60 💬
|
| 500 | NON COMMERCIAL | - | - | - | - | [1] 75 75 💬
|
| 501 | Non disponibile | - | - | - | - | [2] 13 13, 201 💬
|
| 502 | Non intervention-Monitoring device | - | - | - | - | [1] 6 6 💬
|
| 503 | Non invasive ventilation | - | - | - | - | [1] 299 299 💬
|
| 504 | NON PROPIETRY, THEREFORE N/A | - | - | - | - | [1] 51 51 💬
|
| 505 | Non-active stimulation | - | - | - | - | [1] 46 46 💬
|
| 506 | Non-anti-TNF biologics | - | - | - | - | [2] 46 46, 271 💬
|
| 507 | Non-biologic anti-rheumatic drugs | - | - | - | - | [1] 46 46 💬
|
| 508 | Non-biologic Disease Modifying Anti-Rheumatic Drug (DMARD) | - | - | - | - | [1] 46 46 💬
|
| 509 | Non-Biologic DMARDs | - | - | - | - | [3] 46 46, 86, 107 💬
|
| 510 | Non-biological DMARDs | - | - | - | - | [1] 46 46 💬
|
| 511 | Non-enteric coated pancreatic enzyme preparation | - | - | - | - | [1] 298 298 💬
|
| 512 | Non-Interventional Study | - | - | - | - | [1] 97 97 💬
|
| 513 | Non-invasive ultrasound stimulation of the spleen - Treatment Setting 1 | - | - | - | - | [1] 46 46 💬
|
| 514 | Non-invasive ultrasound stimulation of the spleen - Treatment Setting 2 | - | - | - | - | [1] 46 46 💬
|
| 515 | Non-mavacamten symptomatic oHCM therapy | [1] Mavacamten Mavacamten | [1] Mavacamten
Mavacamten
💬
| [1] MYH7 MYH7 💬
| [9] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cardiac muscle contraction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Motor proteins, Thyroid hormone signaling pathway, Viral myocarditis, cGMP-PKG signaling pathway 💬 | [1] 58 58 💬
|
| 516 | Non-myeloablative Hematopoietic Stem Cell Transplantation | - | - | - | - | [1] 93 93 💬
|
| 517 | Non-myeloablative high dose immunosuppressive therapy conditioning (HDIT) | - | - | - | - | [1] 49 49 💬
|
| 518 | Non-nucleoside reverse transcriptase inhibitors | - | - | - | - | [1] 265 265 💬
|
| 519 | Non-pegylated interferon | - | - | - | - | [1] 13 13 💬
|
| 520 | Non-steroidal anti-inflammatory drug | - | - | - | - | [1] 46 46 💬
|
| 521 | Non-steroidal anti-inflammatory drug (NSAID) | - | - | - | - | [1] 46 46 💬
|
| 522 | Non-steroidal anti-inflammatory drugs | - | - | - | - | [1] 46 46 💬
|
| 523 | Non-steroidal anti-inflammatory drugs (NSAIDs) | - | - | - | - | [1] 107 107 💬
|
| 524 | Non-steroidal mineralocorticoid receptor antagonist and SoC | - | - | - | - | [2] 66 66, 223 💬
|
| 525 | Non-TNFi-biologic class | - | - | - | - | [1] 46 46 💬
|
| 526 | Nonbiologic DMARDs of investigator's choice | - | - | - | - | [1] 46 46 💬
|
| 527 | None | - | - | - | - | [14] 13 13, 46, 65, 84, 85, 96, 97, 106, 160, 161, 171, 222, 223, 299 💬
|
| 528 | None as of yet | - | - | - | - | [1] 46 46 💬
|
| 529 | None assigned | - | - | - | - | [2] 231 231, 299 💬
|
| 530 | None at this time | - | - | - | - | [2] 96 96, 140 💬
|
| 531 | None given | - | - | - | - | [1] 97 97 💬
|
| 532 | None yet | - | - | - | - | [3] 51 51, 85, 222 💬
|
| 533 | Nonmyeloablative allogeneic hematopoietic stem cell transplantation | - | - | - | - | [6] 28 28, 51, 60, 62, 65, 285 💬
|
| 534 | Norantipyrine | - | - | - | - | [1] 2 2 💬
|
| 535 | Nordiet | - | - | - | - | [1] 97 97 💬
|
| 536 | Nordimet 7,5 mg solution injectable en stylo prérempli | - | - | - | - | [1] 46 46 💬
|
| 537 | Norditropin | - | - | - | - | [1] 195 195 💬
|
| 538 | Norditropin 24 IU | - | - | - | - | [1] 195 195 💬
|
| 539 | Norditropin FlexPro 10 mg/1.5 ml, solution for injection in pre-filled pen | - | - | - | - | [1] 195 195 💬
|
| 540 | Norditropin SimpleXx | - | - | - | - | [5] 3 3, 97, 107, 193, 195 💬
|
| 541 | Norditropin SimpleXx 15 mg/1.5 ml | - | - | - | - | [1] 3 3 💬
|
| 542 | Norditropin SimpleXx 5mg/1.5ml | - | - | - | - | [1] 107 107 💬
|
| 543 | Norditropine simplex | - | - | - | - | [1] 238 238 💬
|
| 544 | Norditropin® | - | - | - | - | [1] 195 195 💬
|
| 545 | Norditropin® SimpleXx® 5mg/1.5ml | - | - | - | - | [1] 97 97 💬
|
| 546 | Norepinephrine | [1] Norepinephrine Norepinephrine | [3] Noradrenaline
Noradrenaline
,
Norepinephrine bitartrate
,
Norepinephrine hydrochoride
💬
| [9] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬
| [16] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 22 22, 296 💬
|
| 547 | Norepinephrine Bitartrate | [1] Norepinephrine Norepinephrine | [3] Noradrenaline
Noradrenaline
,
Norepinephrine bitartrate
,
Norepinephrine hydrochoride
💬
| [9] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬
| [16] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 296 296 💬
|
| 548 | Norethindrone | - | - | - | - | [2] 13 13, 49 💬
|
| 549 | Norethindrone Acetate-Ethinyl Estradiol | [2] Acetate Acetate, Estradiol | [2] Estradiol
Estradiol
,
Estradiol hemihydrate
💬
| [2] ESR1 ESR1, ESR2 💬
| [10] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | [1] 78 78 💬
|
| 550 | Norgestimate | [1] Norgestimate Norgestimate | [1] Norgestimate
Norgestimate
💬
| [1] PGR PGR 💬
| [5] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | [2] 118 118, 299 💬
|
| 551 | Norgestimate-ethinyl estradiol, with or without folic acid | [3] Estradiol Estradiol, Folic acid, Norgestimate | [5] Folic acid
Folic acid
,
Estradiol
,
Norgestimate
,
Estradiol hemihydrate
,
Folate sodium
💬
| [3] ESR1 ESR1, ESR2, PGR 💬
| [12] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | [1] 118 118 💬
|
| 552 | Normal dietetic scheme | - | - | - | - | [1] 97 97 💬
|
| 553 | Normal human immunoglobulin G | [1] Human immunoglobulin G Human immunoglobulin G | [1] Globulin, immune
Globulin, immune
💬
| - | - | [1] 65 65 💬
|
| 554 | Normal oral intake of the traditional formula | - | - | - | - | [1] 296 296 💬
|
| 555 | Normal Saline | - | - | - | - | [20] 6 6, 13, 17, 22, 36, 46, 49, 60, 70, 71, 79, 94, 96, 97, 210, 211, 226, 276, 296, 299 💬
|
| 556 | Normal Saline (0.9% NaCl) | - | - | - | - | [1] 97 97 💬
|
| 557 | Normal Saline 0.9% Infusion Solution | - | - | - | - | [1] 22 22 💬
|
| 558 | Normal Saline Enema | - | - | - | - | [1] 97 97 💬
|
| 559 | Normal Saline for Injection | - | - | - | - | [1] 13 13 💬
|
| 560 | Normal saline instillation | - | - | - | - | [1] 226 226 💬
|
| 561 | Normal Saline IV Administration | - | - | - | - | [1] 65 65 💬
|
| 562 | Normal saline IV, salt tablets | - | - | - | - | [1] 299 299 💬
|
| 563 | Normal saline solution | - | - | - | - | [1] 299 299 💬
|
| 564 | Normal saline: | - | - | - | - | [1] 299 299 💬
|
| 565 | NORMIX*AD 12CPR RIV 200MG | - | - | - | - | [1] 96 96 💬
|
| 566 | Normotensive patients | - | - | - | - | [1] 70 70 💬
|
| 567 | Norovirus -specific T-cell (NST) therapy | - | - | - | - | [1] 65 65 💬
|
| 568 | Norphenazone | [1] Edaravone Edaravone | [1] Edaravone
Edaravone
💬
| - | - | [1] 2 2 💬
|
| 569 | NORPROLAC | - | - | - | - | [1] 74 74 💬
|
| 570 | Northera | - | - | - | - | [1] 6 6 💬
|
| 571 | Nortriptyline | [1] Nortriptyline Nortriptyline | [2] Nortriptyline hydrochloride
Nortriptyline hydrochloride
,
Nortriptyline
💬
| [2] SLC6A2 SLC6A2, SLC6A4 💬
| [3] Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | [2] 6 6, 226 💬
|
| 572 | Nortriptyline hydrochloride | [1] Nortriptyline Nortriptyline | [2] Nortriptyline hydrochloride
Nortriptyline hydrochloride
,
Nortriptyline
💬
| [2] SLC6A2 SLC6A2, SLC6A4 💬
| [3] Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | [1] 6 6 💬
|
| 573 | Norucholic acid | [1] norUrsodeoxycholic acid norUrsodeoxycholic acid | [1] Norucholic acid
Norucholic acid
💬
| [1] NR1H4 NR1H4 💬
| [1] Bile secretion Bile secretion 💬 | [2] 93 93, 94 💬
|
| 574 | Norucholic acid (NCA) 500 mg | - | - | - | - | [1] 93 93 💬
|
| 575 | Norucholic acid (NCA) 500 mgProduct Code: NCA 500mgPharmaceutical Form: Film-coated tabletINN or Proposed INN: Norucholic acidCAS Number: 9697-24-2Current Sponsor code: NCAOther descriptive name: norucholic acidConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 500-Pharmaceutical form of the placebo: Film-coated tabletRoute of administration of the placebo: Oral use | - | - | - | - | [1] 93 93 💬
|
| 576 | NorUDCA | - | - | - | - | [1] 94 94 💬
|
| 577 | NorUDCA (Norursodeoxycholic acid) | [1] norUrsodeoxycholic acid norUrsodeoxycholic acid | [1] Norucholic acid
Norucholic acid
💬
| [1] NR1H4 NR1H4 💬
| [1] Bile secretion Bile secretion 💬 | [1] 94 94 💬
|
| 578 | NorUrsodeoxycholic Acid | [1] norUrsodeoxycholic acid norUrsodeoxycholic acid | [1] Norucholic acid
Norucholic acid
💬
| [1] NR1H4 NR1H4 💬
| [1] Bile secretion Bile secretion 💬 | [1] 94 94 💬
|
| 579 | Norursodeoxycholic acid, NCA | [1] norUrsodeoxycholic acid norUrsodeoxycholic acid | [1] Norucholic acid
Norucholic acid
💬
| [1] NR1H4 NR1H4 💬
| [1] Bile secretion Bile secretion 💬 | [1] 94 94 💬
|
| 580 | Norvir | - | - | - | - | [2] 265 265, 299 💬
|
| 581 | Norvir 100 mg film-coated tablets | - | - | - | - | [1] 299 299 💬
|
| 582 | NouvNeu001 injection | - | - | - | - | [1] 6 6 💬
|
| 583 | NOVANTRONE*INF 2MG/ML 5ML | - | - | - | - | [1] 13 13 💬
|
| 584 | Novartis Pharmaceuticals Corporation | - | - | - | - | [1] 13 13 💬
|
| 585 | NOVATREX | - | - | - | - | [1] 13 13 💬
|
| 586 | Novo Rapid | - | - | - | - | [1] 299 299 💬
|
| 587 | Novo Rapid Insulin (Novonordisk) | - | - | - | - | [1] 299 299 💬
|
| 588 | Novolin-R insulin | - | - | - | - | [1] 127 127 💬
|
| 589 | NovoNorm 0.5 mg | - | - | - | - | [1] 299 299 💬
|
| 590 | NovoNorm 1 mg | - | - | - | - | [1] 299 299 💬
|
| 591 | NovoNorm 2 mg | - | - | - | - | [1] 299 299 💬
|
| 592 | Novorapid / humalog short acting insulin | - | - | - | - | [1] 299 299 💬
|
| 593 | NovoRapid 100 U/ml, solution for injection in a vial. NovoRapid Penfill 100 U/ml, solution for injection in a cartridge. NovoRapid FlexPen 100 U/ml, solution for injection in a pre-filled pen. | - | - | - | - | [1] 299 299 💬
|
| 594 | NovoRapid Aspartate | - | - | - | - | [1] 299 299 💬
|
| 595 | Now Foods L-Ornithine Capsules | [1] Ornithine Ornithine | [2] Ornithine
Ornithine
,
Ornithine aspartate
💬
| - | - | [1] 96 96 💬
|
| 596 | NOX-E36 | - | - | - | - | [1] 49 49 💬
|
| 597 | Noxafil | - | - | - | - | [2] 65 65, 299 💬
|
| 598 | NOXAFIL - 40 mg/ml oral suspension | - | - | - | - | [1] 299 299 💬
|
| 599 | NOXAFIL - 40 MG/ML SOSPENSIONE ORALE USO ORALE FLACONE (VETRO) 105 ML 1 FLACONE | - | - | - | - | [1] 299 299 💬
|
| 600 | NOXAFIL - oral suspension 40 mg/ml | - | - | - | - | [1] 299 299 💬
|
| 601 | Noxafil 100 mg | - | - | - | - | [1] 299 299 💬
|
| 602 | Noxafil 100 mg Tablets Gastro-Resistant | - | - | - | - | [1] 299 299 💬
|
| 603 | Noxafil 40 mg/ml oral solution | - | - | - | - | [1] 65 65 💬
|
| 604 | Noxafil Gastro resistant tablets | - | - | - | - | [1] 60 60 💬
|
| 605 | Noxafil® | - | - | - | - | [2] 60 60, 299 💬
|
| 606 | NP-201 acetate injection (Part A) | [1] Acetate Acetate | - | - | - | [1] 97 97 💬
|
| 607 | NP001 | - | - | - | - | [1] 2 2 💬
|
| 608 | NP031112 | - | - | - | - | [1] 5 5 💬
|
| 609 | NP031112 600mg | - | - | - | - | [1] 5 5 💬
|
| 610 | NP031112 800mg | - | - | - | - | [1] 5 5 💬
|
| 611 | NPB-01 | - | - | - | - | [3] 13 13, 14, 162 💬
|
| 612 | NPC transplantation | - | - | - | - | [1] 6 6 💬
|
| 613 | NPC-02 | - | - | - | - | [1] 171 171 💬
|
| 614 | NPC-09 | - | - | - | - | [1] 30 30 💬
|
| 615 | NPC-12G gel | - | - | - | - | [2] 34 34, 158 💬
|
| 616 | NPC-12Y gel | - | - | - | - | [1] 158 158 💬
|
| 617 | NPC-14 | - | - | - | - | [1] 113 113 💬
|
| 618 | NPI-001 | - | - | - | - | [2] 90 90, 303 💬
|
| 619 | NPL-2009 | - | - | - | - | [1] 206 206 💬
|
| 620 | Nplate | - | - | - | - | [2] 60 60, 63 💬
|
| 621 | NPLATE 500 microgramos polvo para solución inyectable | - | - | - | - | [1] 63 63 💬
|
| 622 | NPSP 558 | - | - | - | - | [1] 235 235 💬
|
| 623 | NPSP558 | - | - | - | - | [1] 235 235 💬
|
| 624 | NR | - | - | - | - | [1] 299 299 💬
|
| 625 | NR082 Injection | - | - | - | - | [1] 302 302 💬
|
| 626 | NR2B NMDA Antagonist CP-101,606 (traxoprodil) | [1] Traxoprodil Traxoprodil | - | - | - | [1] 6 6 💬
|
| 627 | NS | - | - | - | - | [1] 2 2 💬
|
| 628 | NS 2330 | - | - | - | - | [1] 6 6 💬
|
| 629 | NS-050/NCNP-03 | - | - | - | - | [1] 113 113 💬
|
| 630 | NS-065/NCNP-01 | - | - | - | - | [1] 113 113 💬
|
| 631 | NS-089/NCNP-02 | - | - | - | - | [1] 113 113 💬
|
| 632 | NS-229 | - | - | - | - | [2] 44 44, 45 💬
|
| 633 | NS-304 | - | - | - | - | [1] 86 86 💬
|
| 634 | NS-863 High Dose | - | - | - | - | [1] 86 86 💬
|
| 635 | NS-863 Low Dose | - | - | - | - | [1] 86 86 💬
|
| 636 | NS101 IV infusion | - | - | - | - | [1] 127 127 💬
|
| 637 | NS2330 | - | - | - | - | [1] 6 6 💬
|
| 638 | NSAID | - | - | - | - | [2] 270 270, 271 💬
|
| 639 | NSAIDs | - | - | - | - | [4] 46 46, 70, 107, 271 💬
|
| 640 | NSAIDs (permitted,not necessary) | - | - | - | - | [1] 46 46 💬
|
| 641 | NSAIDs and sulfasalazine | [1] Sulfasalazine Sulfasalazine | [1] Sulfasalazine
Sulfasalazine
💬
| - | - | [1] 271 271 💬
|
| 642 | NsNSAIDs | - | - | - | - | [2] 107 107, 271 💬
|
| 643 | NSP001 | - | - | - | - | [1] 96 96 💬
|
| 644 | NT 101 | - | - | - | - | [4] 5 5, 6, 7, 17 💬
|
| 645 | NT-501 | - | - | - | - | [2] 90 90, 303 💬
|
| 646 | NT-I7 | - | - | - | - | [1] 25 25 💬
|
| 647 | NT-KO-003 | - | - | - | - | [1] 13 13 💬
|
| 648 | NTBC | - | - | - | - | [1] 241 241 💬
|
| 649 | NTCELL Implantation | - | - | - | - | [1] 6 6 💬
|
| 650 | NTI164 | - | - | - | - | [1] 156 156 💬
|
| 651 | NTLA-2001 | [1] NTLA-2001 NTLA-2001 | - | - | - | [1] 28 28 💬
|
| 652 | NTLA-2002 | [1] NTLA-2002 NTLA-2002 | - | - | - | [1] 65 65 💬
|
| 653 | NTQ5082 100mg qd | - | - | - | - | [1] 62 62 💬
|
| 654 | NTQ5082 200mg qd | - | - | - | - | [1] 62 62 💬
|
| 655 | NTQ5082 capsules 100 mg | - | - | - | - | [1] 66 66 💬
|
| 656 | NTQ5082 capsules 200 mg | - | - | - | - | [2] 62 62, 66 💬
|
| 657 | NTQ5082 capsules 300 mg | - | - | - | - | [1] 66 66 💬
|
| 658 | NTR1011 | - | - | - | - | [2] 46 46, 49 💬
|
| 659 | NU100 | - | - | - | - | [1] 13 13 💬
|
| 660 | NUCALA | - | - | - | - | [2] 44 44, 45 💬
|
| 661 | Nucala 100 mg powder for solution for injection | - | - | - | - | [2] 44 44, 45 💬
|
| 662 | NUCALA® | - | - | - | - | [1] 44 44 💬
|
| 663 | NuCel | - | - | - | - | [1] 70 70 💬
|
| 664 | NucleomaxX | - | - | - | - | [1] 265 265 💬
|
| 665 | Nucleoside analogue sparing HAART regimen | - | - | - | - | [1] 265 265 💬
|
| 666 | Nucleoside reverse transcriptase inhibitors | - | - | - | - | [1] 265 265 💬
|
| 667 | Nucresiran | - | - | - | - | [1] 28 28 💬
|
| 668 | Nuedexta | - | - | - | - | [1] 2 2 💬
|
| 669 | Nulojix | - | - | - | - | [1] 46 46 💬
|
| 670 | NUPLAZID | - | - | - | - | [1] 6 6 💬
|
| 671 | NUPLAZID 34 MG Oral Capsule | - | - | - | - | [1] 6 6 💬
|
| 672 | NurOwn (MSC-NTF cells) | - | - | - | - | [2] 2 2, 13 💬
|
| 673 | NurOwn® (MSC-NTF cells) | - | - | - | - | [1] 2 2 💬
|
| 674 | Nursinersen | - | - | - | - | [1] 3 3 💬
|
| 675 | NUSINERSEN | [1] Nusinersen Nusinersen | [2] Nusinersen sodium
Nusinersen sodium
,
Nusinersen
💬
| - | - | [1] 3 3 💬
|
| 676 | Nusinersen Injectable Product | [1] Nusinersen Nusinersen | [2] Nusinersen sodium
Nusinersen sodium
,
Nusinersen
💬
| - | - | [1] 3 3 💬
|
| 677 | NUSINERSEN SODIUM | [1] Nusinersen Nusinersen | [2] Nusinersen sodium
Nusinersen sodium
,
Nusinersen
💬
| - | - | [1] 3 3 💬
|
| 678 | Nusinersen Treatments | [1] Nusinersen Nusinersen | [2] Nusinersen sodium
Nusinersen sodium
,
Nusinersen
💬
| - | - | [1] 3 3 💬
|
| 679 | Nutraceutical Combination | - | - | - | - | [1] 96 96 💬
|
| 680 | Nutridrink-Impact | - | - | - | - | [1] 299 299 💬
|
| 681 | Nutrition supplement | - | - | - | - | [1] 97 97 💬
|
| 682 | Nutrition treat | - | - | - | - | [1] 96 96 💬
|
| 683 | Nutritional dietary intervention | - | - | - | - | [2] 96 96, 97 💬
|
| 684 | Nutritional Formulation Containing Exogenous Ketones | - | - | - | - | [1] 201 201 💬
|
| 685 | Nutritional Ketone Supplement | - | - | - | - | [2] 317 317, 344 💬
|
| 686 | Nutritional Supplement | - | - | - | - | [1] 90 90 💬
|
| 687 | Nutropin AQ | - | - | - | - | [4] 78 78, 134, 193, 299 💬
|
| 688 | Nutropin AQ [somatropin (DNA origin) injection] | - | - | - | - | [1] 299 299 💬
|
| 689 | NutropinAq 10mg/2ml (30 I.E.) Injektionsllösung | - | - | - | - | [1] 65 65 💬
|
| 690 | NutropinAq 10mg/2ml solution for injection | - | - | - | - | [1] 96 96 💬
|
| 691 | NutropinAq® | - | - | - | - | [1] 96 96 💬
|
| 692 | Nuvion®) | - | - | - | - | [1] 97 97 💬
|
| 693 | NUZ-001 | - | - | - | - | [1] 2 2 💬
|
| 694 | NV1205 | - | - | - | - | [1] 20 20 💬
|
| 695 | NVF233 | - | - | - | - | [1] 13 13 💬
|
| 696 | NVG-2089 | - | - | - | - | [2] 14 14, 63 💬
|
| 697 | NW-1015 | - | - | - | - | [1] 6 6 💬
|
| 698 | NW-1015E, EMD 1195686, MSC2191632B | - | - | - | - | [1] 6 6 💬
|
| 699 | NX-13 250 mg | - | - | - | - | [1] 97 97 💬
|
| 700 | NX-13 250mg | - | - | - | - | [1] 97 97 💬
|
| 701 | NX-13 250mg IR | - | - | - | - | [1] 97 97 💬
|
| 702 | NX-13 500mg IR | - | - | - | - | [1] 97 97 💬
|
| 703 | NX-13 500mg MR | - | - | - | - | [1] 97 97 💬
|
| 704 | NX-13 750mg | - | - | - | - | [1] 97 97 💬
|
| 705 | NX1011 | - | - | - | - | [1] 86 86 💬
|
| 706 | NX210c | - | - | - | - | [1] 2 2 💬
|
| 707 | NXC-201 CAR-T | - | - | - | - | [1] 28 28 💬
|
| 708 | NYX-458 | - | - | - | - | [1] 6 6 💬
|
| 709 | Nébivolol | - | - | - | - | [1] 113 113 💬
|